• MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • Prostate Specific Antigen (PSA), Total
  • Phenosense HIV Drug Resistance Replication Capacity
  • Cardiac Myosin Binding Protein C (MYBPC3) Mutation Analysis
  • Cytochrome P450 3A4 (CYP3A4) Genotyping
  • Copper, 24 Hour, Urine
  • Coccidioides By Molecular Method, CSF
  • Primary Hyperoxaluria Gene Mutation Panel
  • Methadone and Metabolites, Confirmation, Urine
  • Fine Needle Aspiration, Breast
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Medical Test

LOINC
Access to MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue is restricted.
Loading...